EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS PREVIOUSLY TREATED WITH FIBRATES OR OBETICHOLIC ACID

Introduction and Objectives: Seladelpar was evaluated as monotherapy or with ursodeoxycholic acid in RESPONSE (NCT04620733) among patients with primary biliary cholangitis. Patients completing RESPONSE could roll over into ASSURE (NCT03301506).Here, we present 18-month (M) data (6M of ASSURE) in pat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alejandra M. Villamil, Daniel Pratt, Andreas E. Kremer, Vincenza Calvaruso, Elena Gómez Dominguez, Xin Qi, Sarah Proehl, William T. Barchuk, Timothy R. Watkins, Stuart C. Gordon
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-09-01
Colecção:	Annals of Hepatology
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S1665268125002765
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!